Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb
ICD-10 C82.34 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiia, lymph nodes of axilla and upper limb.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade IIIa indicates a higher degree of malignancy, with more than 15% of the tumor composed of large cells. This specific code pertains to cases where the lymphoma is localized in the lymph nodes of the axilla and upper limb. Patients may present with painless lymphadenopathy, and the disease can be indolent or aggressive. Staging is crucial, typically using the Ann Arbor system, which assesses the extent of disease spread. B-symptoms, including fever, night sweats, and weight loss, may be present and indicate a more advanced disease state. Treatment protocols often involve a combination of chemotherapy, immunotherapy, and sometimes radiation therapy, tailored to the individual’s disease stage and overall health. Regular follow-up and monitoring for disease progression or transformation to a more aggressive form are essential components of management.
Comprehensive documentation of diagnosis, staging, treatment plans, and follow-up care.
Diagnosis of follicular lymphoma, treatment planning, and management of side effects.
Ensure accurate grading and staging are documented to support coding.
Detailed histopathological reports and grading of lymphoid tissue samples.
Biopsy interpretation and grading of lymphomas.
Pathology reports must clearly indicate the grade and type of lymphoma for accurate coding.
Used during treatment of follicular lymphoma grade IIIa.
Document the specific chemotherapy regimen and patient response.
Oncology specialists must ensure accurate coding of chemotherapy administration.
Common treatments include chemotherapy regimens such as R-CHOP, immunotherapy with monoclonal antibodies, and sometimes radiation therapy, depending on the stage and symptoms.
